Lingwei Jin

522 total citations
21 papers, 402 citations indexed

About

Lingwei Jin is a scholar working on Nephrology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lingwei Jin has authored 21 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Nephrology, 9 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lingwei Jin's work include Renal Diseases and Glomerulopathies (7 papers), Chronic Kidney Disease and Diabetes (4 papers) and Kruppel-like factors research (3 papers). Lingwei Jin is often cited by papers focused on Renal Diseases and Glomerulopathies (7 papers), Chronic Kidney Disease and Diabetes (4 papers) and Kruppel-like factors research (3 papers). Lingwei Jin collaborates with scholars based in China. Lingwei Jin's co-authors include Zhihong Zhou, Yan Chen, Min Pan, Jian Jin, Yu Zheng, Xiaoyan Xu, Wenwen Huang, Yu Zheng, Li‐Ling Wu and Wei Cao and has published in prestigious journals such as Nature Communications, ACS Applied Materials & Interfaces and Antioxidants and Redox Signaling.

In The Last Decade

Lingwei Jin

20 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lingwei Jin China	12	165	150	84	68	50	21	402
Dan Wen China	9	112 0.7×	160 1.1×	28 0.3×	86 1.3×	25 0.5×	31	330
Alia Albawardi United Arab Emirates	11	155 0.9×	132 0.9×	56 0.7×	24 0.4×	101 2.0×	38	447
Ze Bo Hu China	12	139 0.8×	181 1.2×	67 0.8×	33 0.5×	27 0.5×	19	464
Yiwei Kong China	11	81 0.5×	180 1.2×	41 0.5×	102 1.5×	15 0.3×	13	343
Maocai Luo China	6	52 0.3×	149 1.0×	67 0.8×	42 0.6×	43 0.9×	15	299
Han Zhu China	12	148 0.9×	316 2.1×	63 0.8×	134 2.0×	170 3.4×	19	618
Sujuan Xu China	13	110 0.7×	180 1.2×	50 0.6×	52 0.8×	26 0.5×	29	406
De Xie China	12	169 1.0×	186 1.2×	29 0.3×	80 1.2×	102 2.0×	27	452
Veronika Binder Norway	9	120 0.7×	97 0.6×	81 1.0×	56 0.8×	46 0.9×	12	527

Countries citing papers authored by Lingwei Jin

Since Specialization

Citations

This map shows the geographic impact of Lingwei Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingwei Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingwei Jin more than expected).

Fields of papers citing papers by Lingwei Jin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingwei Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingwei Jin. The network helps show where Lingwei Jin may publish in the future.

Co-authorship network of co-authors of Lingwei Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Lingwei Jin. A scholar is included among the top collaborators of Lingwei Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingwei Jin. Lingwei Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Jie, Shuxin Wang, Zhao Min, et al.. (2025). FGF4-FGFR1 signaling promotes podocyte survival and glomerular function to ameliorate diabetic kidney disease in male mice. Nature Communications. 16(1). 10430–10430.

Zhang, Ji, et al.. (2024). Vision transformer introduces a new vitality to the classification of renal pathology. BMC Nephrology. 25(1). 337–337. 2 indexed citations

Zhou, Jie, Xinwei Chen, Wenxin Xu, et al.. (2023). Novel Muscle-Homing Peptide FGF1 Conjugate Based on AlphaFold for Type 2 Diabetes Mellitus. ACS Applied Materials & Interfaces. 15(5). 6397–6410. 4 indexed citations

Huang, Wen Liang, et al.. (2022). A Novel Pyroptosis-Related Prognostic Signature for Risk Stratification and Clinical Prognosis in Clear Cell Renal Cell Carcinoma. Disease Markers. 2022. 1–39. 11 indexed citations

Shen, Meng, Yingjie Gao, Jing Zhang, et al.. (2021). LncRNA CRNDE Exacerbates IgA Nephropathy Progression by Promoting NLRP3 Inflammasome Activation in Macrophages. Immunological Investigations. 51(5). 1515–1527. 18 indexed citations

Wang, Guobao, Li‐Ling Wu, Meng Shi, et al.. (2020). Association of Urinary Matrix Metalloproteinase 7 Levels With Incident Renal Flare in Lupus Nephritis. Arthritis & Rheumatology. 73(2). 265–275. 12 indexed citations

Zhang, Ji, Shufang Pan, Duo Li, et al.. (2020). A nomogram for the prediction of renal outcomes among patients with idiopathic membranous nephropathy. Experimental and Therapeutic Medicine. 20(4). 3130–3137. 9 indexed citations

Wang, Dezhong, Xinyu Zhao, Tianyang Zhao, et al.. (2019). FGF1ΔHBS ameliorates chronic kidney disease via PI3K/AKT mediated suppression of oxidative stress and inflammation. Cell Death and Disease. 10(6). 464–464. 74 indexed citations

Shi, Meng, Lingwei Jin, Li‐Ling Wu, et al.. (2019). Urinary Angiotensinogen Predicts Renal Disease Activity in Lupus Nephritis. Antioxidants and Redox Signaling. 31(17). 1289–1301. 3 indexed citations

10.

Jin, Lingwei, Min Pan, Yan Chen, et al.. (2019). Kruppel‐like factor 4 improves obesity‐related nephropathy through increasing mitochondrial biogenesis and activities. Journal of Cellular and Molecular Medicine. 24(2). 1200–1207. 8 indexed citations

11.

Jin, Lingwei, et al.. (2018). MiR-133a/133b inhibits Treg differentiation in IgA nephropathy through targeting FOXP3. Biomedicine & Pharmacotherapy. 101. 195–200. 21 indexed citations

12.

Zheng, Yu, et al.. (2018). Relationship between Serum Soluble Klotho Protein and Coronary Artery Calcification and Prognosis in Patients on Maintenance Hemodialysis.. PubMed. 47(4). 510–518. 19 indexed citations

13.

Jin, Lingwei, Min Pan, Yu Zheng, et al.. (2018). Down‐regulation of the long non‐coding RNA XIST ameliorates podocyte apoptosis in membranous nephropathy via the miR‐217–TLR4 pathway. Experimental Physiology. 104(2). 220–230. 43 indexed citations

14.

Jin, Lingwei, et al.. (2017). Decreased expression of miR-495 is associated with poor prognosis in clear cell renal cell carcinoma. Biomedical Research-tokyo. 28(13). 5968–5971. 1 indexed citations

15.

Chen, Yan, et al.. (2017). Relationship between serum magnesium level and coronary artery calcification in maintenance hemodialysis patients. 33(2). 106–111. 1 indexed citations

16.

Pan, Min, et al.. (2017). Increased C4 and decreased C3 levels are associated with a poor prognosis in patients with immunoglobulin A nephropathy: a retrospective study. BMC Nephrology. 18(1). 231–231. 26 indexed citations

17.

Cao, Wei, Lingwei Jin, Zhanmei Zhou, et al.. (2016). Overexpression of Intrarenal Renin-Angiotensin System in Human Acute Tubular Necrosis. Kidney & Blood Pressure Research. 41(6). 746–756. 33 indexed citations

18.

Jin, Jian, et al.. (2016). Chlorogenic Acid Attenuates Lipopolysaccharide-Induced Acute Kidney Injury by Inhibiting TLR4/NF-κB Signal Pathway. Inflammation. 40(2). 523–529. 82 indexed citations

19.

Zheng, Yu, et al.. (2015). Cytotoxicity and Genotoxicity in Human Embryonic Kidney Cells Exposed to Surface Modify Chitosan Nanoparticles Loaded with Curcumin. AAPS PharmSciTech. 17(6). 1347–1352. 15 indexed citations

20.

Jin, Lingwei, et al.. (2015). Elevated serum interleukin-35 levels correlate with poor prognosis in patients with clear cell renal cell carcinoma.. PubMed. 8(10). 18861–6. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact